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Rationale: Non-invasive ventilation (NIV) has been shown to improve clinical outcomes in
acute and chronic hypercapnic respiratory failure. A new timed, automated, auto-adaptive
non-invasive ventilatory mode (TA-mode) has been recently introduced.
Objective: To investigate the degree of respiratory muscle unloading with this new mode in
comparison to assisted (S-mode) NIV in healthy individuals.
Methods: Work of breathing, pressure time product and transdiaphragmatic pressure time
product were measured during unassisted breathing, assisted and TA-mode-NIV in eight
healthy, awake volunteers at inspiratory pressures of 20 and expiratory pressures of 4 hPa.
Results: Assisted and TA-mode-NIV reduced the work of breathing by 50 and 89.1%, pressure
time product by 61.5 and 72.6% and transdiaphragmatic pressure time product by 77 and
88.7%, respectively when compared to unassisted breathing. The degree of respiratory muscle
unloading was higher during TA-mode-NIV when compared to assisted non-invasive ventilation
(work of breathing p< 0.001, pressure time product pZ 0.04 and transdiaphragmatic pressure
time product pZ 0,01).
Conclusion: TA-mode-NIV achieved significant higher levels of respiratory muscle unloading in
healthy individuals when compared to assisted non-invasive ventilation.
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There is robust evidence that non-invasive ventilation (NIV)
decreases work of breathing, improves gas exchange and
relieves dyspnea in acute and chronic respiratory failure.1e4
NIV unloads the respiratory muscles and thereby increases
patient mobility5 and endurance.6 The degree of respiratory
muscle unloading depends on the ventilatorymode aswell as
on the level of ventilatory support.7e9.
Auto-adaptive non-invasive ventilation 1707Trigger sensitivity determines the energy that has to be
spent before the ventilator will support the breathing
cycle.10,11 Work to trigger the ventilator can be substantial
and is reported to be as high as 65% of the work of passive
inflation during invasive ventilation12e14 and up to 39%
during NIV.15 During assisted mode ventilation patient
effort does not abruptly cease with the onset of gas
delivery by the ventilator and muscle effort is still present
after the ventilator has started to support the breath.13
Reduction of the breath initiating effort is likely to increase
the degree of respiratory muscle unloading. This could be
achieved by application of controlled ventilator modes
during NIV. Controlled NIV is feasible16 but carries the risk
of patienteventilator asynchrony with increased workload
during inspiration and expiration.17,18 A new ventilator
mode (TAZ timed automated adaptive mode, Weinmann,
Hamburg, Germany) has been introduced into the market.19
This mode is programmed to analyse and closely follow the
patients’ own respiratory pattern in a controlled fashion.
The present study compares the TA mode to the
commonly used assisted mode during NIV by measuring the
degree of inspiratory muscular unloading in healthy and
awake individuals to confirm or refute the presence of more
effective respiratory muscle unloading.
Method
The institutional review board (Medical Association, Wil-
helms University Muenster, Germany, application No. 2006-
532-f-S) approved the protocol. From previous unpublished
data we estimated Cohen’s d to be 3.14 and the effect size to
be 0.84.
Power analysis (Gpower 3.0.10) determined the number
of required measurements to be nZ 7. We recruited eight
healthy volunteers (one female) and obtained informed
consent. Lung function tests were performed using a body
plethysmograph (Masterlab, Jaeger, Wuerzburg, Germany).
Subject characteristics are shown in Table 1.
For each individual a suitable face mask was selected and
adjusted to achieve optimal air tightness and comfort.
Preferably, nose-masks were selected, however a full face
mask was necessary in one individual to accomplish optimal
fit. Volunteers were positioned in a 45 degree upright posi-
tion using a recliner chair. Two balloon catheters (47-8605,
Ackrad Laboratories, Cranford, NJ, USA) were introduced
through the nostrils and advanced with aid of active swal-
lowing into the stomach. Catheters were passed through the
mask by means of two small bore holes which then wereTable 1 Demographic and lung function data, forced
expiratory volume in one second (FEV1), vital capacity (VC).
Mean SD
Age (years) 38 9
BMI 22.6 2.6
FEV1 (l) 4.8 0.5
FEV1% predicted 112.4 11.4
VC (l) 5.6 0.6
VC % predicted 104.1 11.7sealed with plastinate to achieve air tightness (Fig. 1). We
connected catheters to capacitative pressure transducers
(DP 15-36,Validyne, Northridge, CA, USA) connected to an
amplifier (CD223, Validyne, Northridge, CA, USA). A flow
sensor (4700 Series, 0-160 LPM, Hans Rudolph Inc., Kansas
City, MO, USA) was attached between mask and whisper
valve and connected to a pneumotach amplifier (1110, Hans
Rudolph Inc, Kansas City, MO, USA). We captured data on
a personal laptop computer using a customized Lab View
Program (Version 6, National Instruments, Austin, TX, USA)
after A/D conversion (PMD-1208LS converter, Meilhaus
Electronics, Puchheim, Germany) at a sampling rate of
100 Hz.
We calibrated the catheters after inflation with 2.5 cc of
air and retracted one catheter until we obtained opposing
pressure signals and confirmed position with the occlusion
method.20
Ventilator equipment, pressures and modes
We used a Ventilogic non-invasive ventilator (Weinmann,
Hamburg, Germany).
We selected an inspiratory pressure (PI) of 20 hPa for the
following reasons: (1) NIV in chronic hypercapnic patients
has been shown to be effective above a threshold of
18 hPa.21 (2) Selecting pressures higher than 20 hPa have
resulted in marked hyperventilation of the healthy volun-
teers.22 We selected the lowest possible expiratory pres-
sure (PE, 4 hPa) in the absence of airway collapse.
These settings resulted in an effective driving pressure
of 16 hPa, a number shown to be effective in hypercapnic
patients.21
Modes
We applied NIV using assisted (SZ Spontaneous) as well as
TA mode ventilation.
During assisted ventilation inspiratory and expiratory
trigger sensitivity was set to 5 (possible range 1e6, 6 being
most sensitive), PI was set to 20 hPa and PE to 4 hPa.
We measured the effort during unassisted breathing with
the subjects breathing spontaneously through the flow
sensor attached through the mask while the NIV-tubing
system was disconnected.
Description of TA mode
To set up the TA mode one has to select PI, PE, a target
respiratory rate and a range of allowance as well as the type
of expected underlying disease (RZ Restrictive, OZOb-
structive, NZ Normal). The TAmode begins with an analysis
phase. During this phase, a continuous pressure of 4 hPa is
maintained to guarantee effective carbon dioxide washout
through the whisper valve. During this phase, the ventilator
analyzes the patients own flow profile by integration of flow
and time (Fig. 2). Once the ventilator senses a stable profile
(time and flow measurements within a predefined range of
allowance), the ventilator will increase PI over five consec-
utive breaths in steps of 60e70e80e90e100% of preset PI
(Fig. 2). During the inspiratory phase, PI will be adjusted over
Figure 1 Experimental setup with full face mask (A) and nose mask (B). Esophageal and gastric catheters (C) are passed through
small bore holes, sealed with plastinate. A flow-sensor is attached distal to the whisper valve.
1708 D. Dellweg et al.inspiratory time in order to obtain a flowprofilematching the
patients’ own pattern.
The inspiratory pressure curve is being calculated
according to the following motion equation (equation (1)):
PðtÞZR flowþ 1=C volume 1
P(t) represents the pressure integral, flow and volume
arise from averaged flow pattern data from the analysis
phase. The selection RZ Restrictive, OZObstructive and
NZ Normal allocates distinct constant numbers for resis-
tance (R given in hPa/(l/s)) and compliance (C given in ml/Figure 2 Pressure and flow tracings during the analysis phase a
mode). According to the measured flow profile of spontaneous bre
during the run in period, resulting in increased inspiratory flow (fl
ratory muscle unloading.hPa) into the equation (Table 2). The system software
calculates P(t) according to the individual pre-selected
maximal inspiratory pressures.
Inspiratory time refers to the average inspiratory time
recorded during the analysis phase. We selected a broad
range of the respiratory rate to allow each individual to
achieve his or her natural respiratory rate. The target
rateerange selection can be used to prevent an inept and
non-physiological breathing pattern.
Inspiratory to expiratory time ratio (I:E ratio) is deter-
mined by the subjects’ I:E ratio measured during thend run in period of auto-adaptive controlled ventilation (TA-
athing, the ventilator slowly increases inspiratory pressure (PI)
ow) and raised esophageal pressure (Poes), a marker of respi-
Table 2 Selection of the type of underlying disease
changes the values for resistance and compliance in the
motion equation [P(t)Z R flowþ 1/C volume].




Figure 3 Pressure time product (PTP) during unassisted
breathing, S-mode and TA-mode non-invasive ventilation.
Auto-adaptive non-invasive ventilation 1709analysis phase. TA mode does not allow for additional
triggered breaths, however if the ventilator senses sub-
jecteventilator asynchrony, it will reanalyze the patients
flow pattern. Asynchrony is defined by inspiratory and/or
expiratory fighting in four consecutive breaths. Inspiratory
fighting is defined by a flow reduction of at least 20 l/min
below the mean inspiratory flow inside the middle 60% of
the inspiratory time (between TI20 and TI80). Expiratory
fighting is defined by the presence of flow rise of 10 l/min
above leak-compensation inside the middle 40% of the
expiratory time (between TE30 and TE 70).
Measurements, data analysis and assessment
of respiratory effort
We recorded all data during a 5-min period following
a 5 min interval of stabilization (respiratory rate and
minute-ventilation 5%). Our software compiled one data
set for each 30 sec interval including esophageal and gastric
pressure, flow as well as time.
We performed offline analysis of data sets using
a customized software module based on the lab-view
software version 6.0 (National Instruments, Austin, TX,
USA).
Chest wall compliance (Ccw) was estimated to be 4% of
vital capacity per hPa.23 To exclude leak flow during the
experiment inspiratory and expiratory volume for each
breath, we had to match with an allowance of less than
3% per breath.
The module was programmed to calculate the following
parameters:
1. Total inspiratory work of breathing (WOB) was calcu-
lated from the area between the inspiratory pressure
volume curve and the line of chest wall compliance
using esophageal pressure tracings. The interception of
the Ccw line with the X-axis was set to the point of
inspiratory flow onset for lower bound calculation and
to the point of expiratory flow cessation for upper
bound calculation. We calculated WOB in joule per litre
of ventilation.
2. Total inspiratory pressure time product (PTP) was
measured as the time integral of the difference
between the esophageal pressure tracing and the recoil
pressure of the chest wall. The latter was calculated by
multiplying the estimated Ccw and measured inspira-
tory volume. PTP is expressed in hPa*s/l.
3. Inspiratory transdiaphragmatic pressure time product
(PTPdi) was calculated by subtraction of gastric from
esophageal pressure. PTPdi is defined as the total areaof the resulting curve below baseline. PTPdi is
expressed in hPa*s/l.
4. Parameters that define respiratory pattern such as tidal
volume (VT in litres), respiratory rate (fR in breath per
minute), minute ventilation ( _V in l/min) and inspiratory
time (TI in %)
We calculated PTP and PTPdi according to upper and
lower bound criteria. For upper bound the marker was set
to the beginning of rapid decrease of the pressure curves
whereas lower bound marker was set to onset of inspiratory
flow.24 As expected, in the absence of airway disease upper
and lower bound measurements did not differ and we
limited data presentation to lower bound measurements.
We randomized the order of the three different runs
(unassisted breathing, assisted-mode and TA-mode).
Statistics
Differences for the three different runs were evaluated by
means of one-way ANOVA (Scheffe´ procedure for post hoc
analysis).
Results
PTP, PTPdi and WOB for unassisted breathing, assisted-
mode and TA-mode supported breathing are shown in Figs.
3e5. Compared to unassisted breathing, assisted as well as
TA-mode ventilation achieved significant reductions in all
three measured parameters (p< 0.001). The level of
remaining respiratory muscle work during TA-mode venti-
lation was lower compared to assisted-mode ventilation
(p< 0.05 or less, see figures for details).
Table 3 shows to what extent PTP, PTPdi and WOB have
been reduced during assisted and TA-mode ventilation. As
Figure 4 Pressure time product of transdiaphragmatic pres-
sures (PTPdi) during unassisted breathing, S-mode and TA-
mode non-invasive ventilation.
Table 3 Pressure time product (PTP, hPa*s/l), pressure
time product of transdiaphragmatic pressures (PTPdi,
hPa*s/l) and work of breathing (WOB, j/l) have been
reduced by the different forms of NIV to the percentage
given in this table.
PTP PTPdi WOB
Unassisted 100% 100% 100%
S-mode NIV 38.5% 33% 50%
TA-mode NIV 27.4% 11.3% 10.9%
1710 D. Dellweg et al.expected in healthy individuals, the addition of NIV
increased VT and _V (Table 4). We also observed an increase
in fB. During the period of data collection, we found no
ineffective triggering or subject ventilator asynchrony by
manual analysis of the pressure and flow curves.
Discussion
TA-mode NIV significantly decreases respiratory muscle
load when compared to assisted-mode NIV in healthy awakeFigure 5 Work of breathing (WOB) during unassisted
breathing, S-mode and TA-mode non-invasive ventilation.individuals. The reduction of the respiratory workload is
considerable and reaches almost up to 90% when compared
to spontaneous breathing and up to 39% in comparison to
assisted ventilation depending on the examined variable.
Our variables (WOB, PTP and PTPdi) measure muscular
effort throughout the inspiratory portion of the breathing
cycle. Previous studies in patients with COPD have shown,
that the respiratory muscle effort, necessary to activate
the inspiratory trigger is already estimated to be some-
where between 26 and 39%.15 Total inspiratory muscular
unloading of ventilator modes avoiding trigger effort could
therefore exceed this number in the presence of obstruc-
tive airway disease.
With the results displayed in table four it becomes
evident, that inspiratory time during TA mode ventilation
correlates quite well to the inspiratory time during unas-
sisted breathing. This was not unexpected, since one major
objective of TA mode ventilation was to deliver a flow-
pattern, that matches the patients or subjects own flow
pattern at a slightly higher respiratory rate. To achieve this
goal the software algorithm will adjust the inspiratory
pressure during each breath in order to match the previ-
ously measured target flow profile. This implies that the
programmed inspiratory pressure during TA mode ventila-
tion will only be reached at peak inspiratory flow, whereas
inspiratory pressure during assisted ventilation will be held
throughout the whole inspiratory time. The latter mecha-
nism and the higher subject effort during assisted ventila-
tion resulted in more pronounced hyperventilation in our
healthy subjects (Table 4).
We did not observe subject-ventilator asynchrony during
our measurements. Previous studies have shown that
inappropriate termination of the mechanical inflation can
increase the workload of the succeeding breath and might
cause ineffective triggering and asynchrony in the presence
of increased expiratory resistance.18,25 There is an absoluteTable 4 Tidal volume (VT), respiratory frequency (fR),
minute ventilation ( _V) and inspiratory fraction (TI) during
unassisted breathing as well as assisted (S-mode) NIV and
auto-adaptive (TA-mode) NIV. Inspiratory pressure 20 and
expiratory pressure 4 hPa.
VT (I) fR (min
1) _V (l/min) TI (%)
Unassisted 0.7 0.15 11.7 2 7.9 1.1 45.9 2.4
S-mode NIV 1.4 0.38 13.2 2.7 17.5 3.6 40.6 5.6
TA-mode NIV 1.0 0.3 14.8 2.3 14.7 3.7 45.3 2.4
Auto-adaptive non-invasive ventilation 1711need to evaluate, if such mechanisms are present in TA-
mode ventilated patients. Invasive measurements in
chronic respiratory failure (CRF) patients during different
sleep stages as well as clinical data are necessary before
recommendations for the use of TA-mode ventilation can be
given.
NIV improves respiratory muscle performance by sup-
porting and resting respiratory muscles during periods of
ventilation.1,26e28 The level of pressure support is probably
the most important variable determining respiratory muscle
unloading. This might be the reason why some investigators
failed to find positive effects of NIV in CRF 3,29,30 using
lower pressures while others found improvements using
higher inspiratory pressures.3,16,31
The total extent of muscular unloading during NIV is
being defined by the degree of muscular unloading during,
and the time of NIV application.
No study so far has investigated the optimal composition
of these two parameters and it is likely that optimal
composition is dependant on disease type and severity.
Complete respiratory muscle unloading however has
been associated with development of diaphragmatic
dysfunction (VIDD).32
In our experiments, we were not able to completely
suppress respiratory muscle activity with either mode of
ventilation. This may be different, when ventilatory response
decreases during sleep,33 especially in patients with respira-
tory failure.34 The role of NIV induced VIDD has still to be
defined and should be viewed in regard of degree and time of
muscular unloading during NIV in future studies.
Conclusion
Auto-adaptive controlled NIV increases the degree of
respiratory muscle unloading when compared to assisted
NIV in our experiments in awake and healthy individuals.
Invasive measurements in patients with respiratory failure
and clinical data are necessary to define the future role of
TA-mode ventilation.
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